Glycosphingolipid–protein interaction in signal transduction

International Journal of Molecular Sciences

Volumn 17, Issue 10, 2016, Pages

  Russo, Domenico ^a   Parashuraman, Seetharaman ^a   D’Angelo, Giovanni ^a,b  

^a INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

^b IRCCS SDN   (Italy)

Author keywords

Glycan protein interaction; Glycosphingolipid; Signalling

Indexed keywords

CD19 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOSPHINGOLIPID; PROTEIN; CELL SURFACE RECEPTOR; GANGLIOSIDE; PROTEIN BINDING;

CELL MATURATION; DIFFERENTIATION; INSULIN SENSITIVITY; LIGAND BINDING; LIPID METABOLISM; NONHUMAN; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; ANIMAL; CELL DIFFERENTIATION; EMBRYOLOGY; MAMMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; GANGLIOSIDES; GLYCOSPHINGOLIPIDS; MAMMALS; PROTEIN BINDING; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 84991627616     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17101732     Document Type: Review

References (184)

1. Merrill, A.H. Jr. Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem. Rev. 2011, 111, 6387–6422.
2. Coskun, U.; Grzybek, M.; Drechsel, D.; Simons, K. Regulation of human EGF receptor by lipids. Proc. Natl. Acad. Sci. USA 2011, 108, 9044–9048.
3. Vyas, K.A.; Patel, H.V.; Vyas, A.A.; Schnaar, R.L. Segregation of gangliosides GM1 and GD3 on cell membranes, isolated membrane rafts, and defined supported lipid monolayers. Biol. Chem. 2001, 382, 241–250.
4. Kiyokawa, E.; Baba, T.; Otsuka, N.; Makino, A.; Ohno, S.; Kobayashi, T. Spatial and functional heterogeneity of sphingolipid-rich membrane domains. J. Biol. Chem. 2005, 280, 24072–24084.
5. Lindquist, S.; Karitkina, D.; Langnaese, K.; Posevitz-Fejfar, A.; Schraven, B.; Xavier, R.; Seed, B.; Lindquist, J.A. Phosphoprotein associated with glycosphingolipid-enriched microdomains differentially modulates SRC kinase activity in brain maturation. PLoS ONE 2011, 6, e23978.
6. Ideo, H.; Seko, A.; Ishizuka, I.; Yamashita, K. The N-terminal carbohydrate recognition domain of galectin-8 recognizes specific glycosphingolipids with high affinity. Glycobiology 2003, 13, 713–723.
7. Sprong, H.; Degroote, S.; Nilsson, T.; Kawakita, M.; Ishida, N.; van der Sluijs, P.; van Meer, G. Association of the Golgi UDP-galactose transporter with UDP-galactose:ceramide galactosyltransferase allows UDP-galactose import in the endoplasmic reticulum. Mol. Biol. Cell 2003, 14, 3482–3493.
8. Schulze, H.; Sandhoff, K. Lysosomal lipid storage diseases. Cold Spring Harb. Perspect. Biol. 2011, 3.
9. Hamel, S.; Fantini, J.; Schweisguth, F. Notch ligand activity is modulated by glycosphingolipid membrane composition in Drosophila melanogaster. J. Cell Biol. 2010, 188, 581–594.
10. Minoguchi, K.; Swaim, W.D.; Berenstein, E.H.; Siraganian, R.P. Src family tyrosine kinase p53/56lyn, a serine kinase and Fc epsilon RI associate with -galactosyl derivatives of ganglioside GD1b in rat basophilic leukemia RBL-2H3 cells. J. Biol. Chem. 1994, 269, 5249–5254.
11. Kasahara, K.; Watanabe, Y.; Yamamoto, T.; Sanai, Y. Association of Src family tyrosine kinase Lyn with ganglioside GD3 in rat brain: Possible regulation of Lyn by glycosphingolipid in caveolae-like domains. J. Biol. Chem. 1997, 272, 29947–29953.
12. Yamamura, S.; Handa, K.; Hakomori, S. A close association of GM3 with c-Src and Rho in GM3-enriched microdomains at the B16 melanoma cell surface membrane: A preliminary note. Biochem. Biophys. Res. Commun. 1997, 236, 218–222.
13. Iwabuchi, K.; Yamamura, S.; Prinetti, A.; Handa, K.; Hakomori, S. GM3-enriched microdomain involved in cell adhesion and signal transduction through carbohydrate-carbohydrate interaction in mouse melanoma B16 cells. J. Biol. Chem. 1998, 273, 9130–9138.
14. Holleran, W.M.; Takagi, Y.; Menon, G.K.; Legler, G.; Feingold, K.R.; Elias, P.M. Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J. Clin. Investig. 1993, 91, 1656–1664.
15. Holleran, W.M.; Ginns, E.I.; Menon, G.K.; Grundmann, J.U.; Fartasch, M.; McKinney, C.E.; Elias, P.M.; Sidransky, E. Consequences of β-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J. Clin. Investig. 1994, 93, 1756–1764.
16. Jennemann, R.; Sandhoff, R.; Langbein, L.; Kaden, S.; Rothermel, U.; Gallala, H.; Sandhoff, K.; Wiegandt, H.; Gröne, H.J. Integrity and barrier function of the epidermis critically depend on glucosylceramide synthesis. J. Biol. Chem. 2007, 282, 3083–3094.
17. Lingwood, C.A. Glycosphingolipid functions. Cold Spring Harb. Perspect. Biol. 2011, 3.
18. Hakomori, S.I. Structure and function of glycosphingolipids and sphingolipids: Recollections and future trends. Biochim. Biophys. Acta 2008, 1780, 325–346.
19. Mirkin, B.L.; Clark, S.H.; Zhang, C. Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B. Cell Prolif. 2002, 35, 105–115.
20. Park, S.Y.; Kwak, C.Y.; Shayman, J.A.; Kim, J.H. Globoside promotes activation of ERK by interaction with the epidermal growth factor receptor. Biochim. Biophys. Acta 2012, 1820, 1141–1148.
21. Guan, F.; Handa, K.; Hakomori, S.I. Regulation of epidermal growth factor receptor through interaction of ganglioside GM3 with GlcNAc of N-linked glycan of the receptor: Demonstration in ldlD cells. Neurochem. Res. 2011, 36, 1645–1653.
22. Bremer, E.G.; Hakomori, S. GM3 ganglioside induces hamster fibroblast growth inhibition in chemically-defined medium: Ganglioside may regulate growth factor receptor function. Biochem. Biophys. Res. Commun. 1982, 106, 711–718.
23. Bremer, E.G.; Hakomori, S.; Bowen-Pope, D.F.; Raines, E.; Ross, R. Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J. Biol. Chem. 1984, 259, 6818–6825.
24. Mutoh, T.; Tokuda, A.; Miyadai, T.; Hamaguchi, M.; Fujiki, N. Ganglioside GM1 binds to the Trk protein and regulates receptor function. Proc. Natl. Acad. Sci. USA 1995, 92, 5087–5091.
25. Kimura, M.; Hidari, K.I.; Suzuki, T.; Miyamoto, D.; Suzuki, Y. Engagement of endogenous ganglioside GM1a induces tyrosine phosphorylation involved in neuron-like differentiation of PC12 cells. Glycobiology 2001, 11, 335–343.
26. Kabayama, K.; Sato, T.; Saito, K.; Loberto, N.; Prinetti, A.; Sonnino, S.; Kinjo, M.; Igarashi, Y.; Inokuchi, J. Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc. Natl. Acad. Sci. USA 2007, 104, 13678–13683.
27. Tagami, S.; Inokuchi Ji, J.; Kabayama, K.; Yoshimura, H.; Kitamura, F.; Uemura, S.; Ogawa, C.; Ishii, A.; Saito, M.; Ohtsuka, Y.; et al. Ganglioside GM3 participates in the pathological conditions of insulin resistance. J. Biol. Chem. 2002, 277, 3085–3092.
28. Kondo, Y.; Ikeda, K.; Tokuda, N.; Nishitani, C.; Ohto, U.; Akashi-Takamura, S.; Ito, Y.; Uchikawa, M.; Kuroki, Y.; Taguchi, R.; et al. TLR4-MD-2 complex is negatively regulated by an endogenous ligand, globotetraosylceramide. Proc. Natl. Acad. Sci. USA 2013, 110, 4714–4719.
29. Chakrabandhu, K.; Huault, S.; Garmy, N.; Fantini, J.; Stebe, E.; Mailfert, S.; Marguet, D.; Hueber, A.O. The extracellular glycosphingolipid-binding motif of Fas defines its internalization route, mode and outcome of signals upon activation by ligand. Cell Death Differ. 2008, 15, 1824–1837.
30. Kim, D.S.; Son, K.Y.; Koo, K.M.; Kim, J.Y.; Alfajaro, M.M.; Park, J.G.; Hosmillo, M.; Soliman, M.; Baek, Y.B.; Cho, E.H.; et al. Porcine sapelovirus uses 2, 3-linked sialic acid on GD1a ganglioside as a receptor. J. Virol. 2016, 90, 4067–4077.
31. Rydell, G.E.; Dahlin, A.B.; Hook, F.; Larson, G. QCM-D studies of human norovirus VLPs binding to glycosphingolipids in supported lipid bilayers reveal strain-specific characteristics. Glycobiology 2009, 19, 1176–1184.
32. Le Pendu, J.; Ruvoen-Clouet, N.; Kindberg, E.; Svensson, L. Mendelian resistance to human norovirus infections. Semin. Immunol. 2006, 18, 375–386.
33. Rydell, G.E.; Svensson, L.; Larson, G.; Johannes, L.; Romer, W. Human GII.4 norovirus VLP induces membrane invaginations on giant unilamellar vesicles containing secretor gene dependent 1, 2-fucosylated glycosphingolipids. Biochim. Biophys. Acta 2013, 1828, 1840–1845.
34. Taube, S.; Perry, J.W.; Yetming, K.; Patel, S.P.; Auble, H.; Shu, L.; Nawar, H.F.; Lee, C.H.; Connell, T.D.; Shayman, J.A.; et al. Ganglioside-linked terminal sialic acid moieties on murine macrophages function as attachment receptors for murine noroviruses. J. Virol. 2009, 83, 4092–4101.
35. Taube, S.; Perry, J.W.; McGreevy, E.; Yetming, K.; Perkins, C.; Henderson, K.; Wobus, C.E. Murine noroviruses bind glycolipid and glycoprotein attachment receptors in a strain-dependent manner. J. Virol. 2012, 86, 5584–5593.
36. Zakhour, M.; Ruvoen-Clouet, N.; Charpilienne, A.; Langpap, B.; Poncet, D.; Peters, T.; Bovin, N.; Le Pendu, J. The Gal epitope of the histo-blood group antigen family is a ligand for bovine norovirus Newbury2 expected to prevent cross-species transmission. PLoS Pathog. 2009, 5, e1000504.
37. Ruvoen-Clouet, N.; Ganiere, J.P.; Andre-Fontaine, G.; Blanchard, D.; Le Pendu, J. Binding of rabbit hemorrhagic disease virus to antigens of the ABH histo-blood group family. J. Virol. 2000, 74, 11950–11954.
38. Nilsson, E.C.; Storm, R.J.; Bauer, J.; Johansson, S.M.; Lookene, A.; Angstrom, J.; Hedenstrom, M.; Eriksson, T.L.; Frangsmyr, L.; Rinaldi, S.; et al. The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis. Nat. Med. 2011, 17, 105–109.
39. Stencel-Baerenwald, J.; Reiss, K.; Blaum, B.S.; Colvin, D.; Li, X.N.; Abel, T.; Boyd, K.; Stehle, T.; Dermody, T.S. Glycan engagement dictates hydrocephalus induction by serotype 1 reovirus. mBio 2015, 6, e02356.
40. Rolsma, M.D.; Gelberg, H.B.; Kuhlenschmidt, M.S. Assay for evaluation of rotavirus-cell interactions: Identification of an enterocyte ganglioside fraction that mediates group A porcine rotavirus recognition. J. Virol. 1994, 68, 258–268.
41. Rolsma, M.D.; Kuhlenschmidt, T.B.; Gelberg, H.B.; Kuhlenschmidt, M.S. Structure and function of a ganglioside receptor for porcine rotavirus. J. Virol. 1998, 72, 9079–9091.
42. Haselhorst, T.; Fleming, F.E.; Dyason, J.C.; Hartnell, R.D.; Yu, X.; Holloway, G.; Santegoets, K.; Kiefel, M.J.; Blanchard, H.; Coulson, B.S.; et al. Sialic acid dependence in rotavirus host cell invasion. Nat. Chem. Biol. 2009, 5, 91–93.
43. Martinez, M.A.; Lopez, S.; Arias, C.F.; Isa, P. Gangliosides have a functional role during rotavirus cell entry. J. Virol. 2013, 87, 1115–1122.
44. Delorme, C.; Brussow, H.; Sidoti, J.; Roche, N.; Karlsson, K.A.; Neeser, J.R.; Teneberg, S. Glycosphingolipid binding specificities of rotavirus: Identification of a sialic acid-binding epitope. J. Virol. 2001, 75, 2276–2287.
45. Dormitzer, P.R.; Sun, Z.Y.; Blixt, O.; Paulson, J.C.; Wagner, G.; Harrison, S.C. Specificity and affinity of sialic acid binding by the rhesus rotavirus VP8* core. J. Virol. 2002, 76, 10512–10517.
46. Fukudome, K.; Yoshie, O.; Konno, T. Comparison of human, simian, and bovine rotaviruses for requirement of sialic acid in hemagglutination and cell adsorption. Virology 1989, 172, 196–205.
47. Guo, C.T.; Nakagomi, O.; Mochizuki, M.; Ishida, H.; Kiso, M.; Ohta, Y.; Suzuki, T.; Miyamoto, D.; Hidari, K.I.; Suzuki, Y. Ganglioside GMia on the cell surface is involved in the infection by human rotavirus KUN and MO strains. J. Biochem. 1999, 126, 683–688.
48. Fleming, F.E.; Bohm, R.; Dang, V.T.; Holloway, G.; Haselhorst, T.; Madge, P.D.; Deveryshetty, J.; Yu, X.; Blanchard, H.; von Itzstein, M.; et al. Relative roles of GM1 ganglioside, N-acylneuraminic acids, and α2β1 integrin in mediating rotavirus infection. J. Virol. 2014, 88, 4558–4571.
49. Yu, X.; Coulson, B.S.; Fleming, F.E.; Dyason, J.C.; von Itzstein, M.; Blanchard, H. Novel structural insights into rotavirus recognition of ganglioside glycan receptors. J. Mol. Biol. 2011, 413, 929–939.
50. Stroh, L.J.; Gee, G.V.; Blaum, B.S.; Dugan, A.S.; Feltkamp, M.C.; Atwood, W.J.; Stehle, T. Trichodysplasia spinulosa-associated polyomavirus uses a displaced binding site on VP1 to engage sialylated glycolipids. PLoS Pathog. 2015, 11, e1005112.
51. Tsai, B.; Gilbert, J.M.; Stehle, T.; Lencer, W.; Benjamin, T.L.; Rapoport, T.A. Gangliosides are receptors for murine polyoma virus and SV40. EMBO J. 2003, 22, 4346–4355.
52. You, J.; O’Hara, S.D.; Velupillai, P.; Castle, S.; Levery, S.; Garcea, R.L.; Benjamin, T. Ganglioside and non-ganglioside mediated host responses to the mouse polyomavirus. PLoS Pathog. 2015, 11, e1005175.
53. Ewers, H.; Romer, W.; Smith, A.E.; Bacia, K.; Dmitrieff, S.; Chai, W.; Mancini, R.; Kartenbeck, J.; Chambon, V.; Berland, L.; et al. GM1 structure determines SV40-induced membrane invagination and infection. Nat. Cell Biol. 2010, 12, 11–18.
54. Neu, U.; Woellner, K.; Gauglitz, G.; Stehle, T. Structural basis of GM1 ganglioside recognition by simian virus 40. Proc. Natl. Acad. Sci. USA 2008, 105, 5219–5224.
55. Low, J.A.; Magnuson, B.; Tsai, B.; Imperiale, M.J. Identification of gangliosides GD1b and GT1b as receptors for BK virus. J. Virol. 2006, 80, 1361–1366.
56. Komagome, R.; Sawa, H.; Suzuki, T.; Suzuki, Y.; Tanaka, S.; Atwood, W.J.; Nagashima, K. Oligosaccharides as receptors for JC virus. J. Virol. 2002, 76, 12992–13000.
57. Erickson, K.D.; Garcea, R.L.; Tsai, B. Ganglioside GT1b is a putative host cell receptor for the Merkel cell polyomavirus. J. Virol. 2009, 83, 10275–10279.
58. Brown, K.E.; Anderson, S.M.; Young, N.S. Erythrocyte P antigen: Cellular receptor for B19 parvovirus. Science 1993, 262, 114–117.
59. Nasir, W.; Nilsson, J.; Olofsson, S.; Bally, M.; Rydell, G.E. Parvovirus B19 VLP recognizes globoside in supported lipid bilayers. Virology 2014, 456–457, 364–369.
60. Brown, K.E.; Liu, Z.; Gallinella, G.; Wong, S.; Mills, I.P.; O’Sullivan, M.G. Simian parvovirus infection: A potential zoonosis. J. Infect. Dis. 2004, 190, 1900–1907.
61. Schmidt, M.; Chiorini, J.A. Gangliosides are essential for bovine adeno-associated virus entry. J. Virol. 2006, 80, 5516–5522.
62. Hammache, D.; Pieroni, G.; Yahi, N.; Delezay, O.; Koch, N.; Lafont, H.; Tamalet, C.; Fantini, J. Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3. J. Biol. Chem. 1998, 273, 7967–7971.
63. Hammache, D.; Yahi, N.; Pieroni, G.; Ariasi, F.; Tamalet, C.; Fantini, J. Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: Implications for the role of glycolipids as potential HIV-1 fusion cofactors. Biochem. Biophys. Res. Commun. 1998, 246, 117–122.
64. Hammache, D.; Yahi, N.; Maresca, M.; Pieroni, G.; Fantini, J. Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: Evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3). J. Virol. 1999, 73, 5244–5248.
65. Hug, P.; Lin, H.M.; Korte, T.; Xiao, X.; Dimitrov, D.S.; Wang, J.M.; Puri, A.; Blumenthal, R. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5. J. Virol. 2000, 74, 6377–6385.
66. Bhat, S.; Spitalnik, S.L.; Gonzalez-Scarano, F.; Silberberg, D.H. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 1991, 88, 7131–7134.
67. Bhat, S.; Mettus, R.V.; Reddy, E.P.; Ugen, K.E.; Srikanthan, V.; Williams, W.V.; Weiner, D.B. The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206–275. AIDS Res. Hum. Retrovir. 1993, 9, 175–181.
68. Rawat, S.S.; Johnson, B.T.; Puri, A. Sphingolipids: Modulators of HIV-1 infection and pathogenesis. Biosci. Rep. 2005, 25, 329–343.
69. Cook, D.G.; Fantini, J.; Spitalnik, S.L.; Gonzalez-Scarano, F. Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): Relationship to the V3 loop. Virology 1994, 201, 206–214.
70. Wang, K.; Wang, J.; Sun, T.; Bian, G.; Pan, W.; Feng, T.; Wang, P.; Li, Y.; Dai, J. Glycosphingolipid GM3 is Indispensable for Dengue Virus Genome Replication. Int. J. Biol. Sci. 2016, 12, 872–883.
71. Hidari, K.I.; Abe, T.; Suzuki, T. Carbohydrate-related inhibitors of dengue virus entry. Viruses 2013, 5, 605–618.
72. Wichit, S.; Jittmittraphap, A.; Hidari, K.I.; Thaisomboonsuk, B.; Petmitr, S.; Ubol, S.; Aoki, C.; Itonori, S.; Morita, K.; Suzuki, T.; et al. Dengue virus type 2 recognizes the carbohydrate moiety of neutral glycosphingolipids in mammalian and mosquito cells. Microbiol. Immunol. 2011, 55, 135–140.
73. Meisen, I.; Dzudzek, T.; Ehrhardt, C.; Ludwig, S.; Mormann, M.; Rosenbruck, R.; Lumen, R.; Kniep, B.; Karch, H.; Muthing, J. The human H3N2 influenza viruses A/Victoria/3/75 and A/Hiroshima/52/2005 preferentially bind to 2–3-sialylated monosialogangliosides with fucosylated poly-N-acetyllactosaminyl chains. Glycobiology 2012, 22, 1055–1076.
74. Perino, J.; Crouzier, D.; Spehner, D.; Debouzy, J.C.; Garin, D.; Crance, J.M.; Favier, A.L. Lung surfactant DPPG phospholipid inhibits vaccinia virus infection. Antivir. Res. 2011, 89, 89–97.
75. Perino, J.; Foo, C.H.; Spehner, D.; Cohen, G.H.; Eisenberg, R.J.; Crance, J.M.; Favier, A.L. Role of sulfatide in vaccinia virus infection. Biol. Cell 2011, 103, 319–331.
76. Ferreira, L.; Villar, E.; Munoz-Barroso, I. Gangliosides and N-glycoproteins function as Newcastle disease virus receptors. Int. J. Biochem. Cell Biol. 2004, 36, 2344–2356.
77. Epand, R.M.; Nir, S.; Parolin, M.; Flanagan, T.D. The role of the ganglioside GD1a as a receptor for Sendai virus. Biochemistry 1995, 34, 1084–1089.
78. Suzuki, T.; Portner, A.; Scroggs, R.A.; Uchikawa, M.; Koyama, N.; Matsuo, K.; Suzuki, Y.; Takimoto, T. Receptor specificities of human respiroviruses. J. Virol. 2001, 75, 4604–4613.
79. Jobling, M.G.; Holmes, R.K. Mutational analysis of ganglioside GM1-binding ability, pentamer formation, and epitopes of cholera toxin B (CTB) subunits and CTB/heat-labile enterotoxin B subunit chimeras. Infect. Immun. 2002, 70, 1260–1271.
80. Heyningen, S.V. Cholera toxin: Interaction of subunits with ganglioside GM1. Science 1974, 183, 656–657.
81. Lencer, W.I.; Saslowsky, D. Raft trafficking of AB5 subunit bacterial toxins. Biochim. Biophys. Acta 2005, 1746, 314–321.
82. Jacewicz, M.; Clausen, H.; Nudelman, E.; Donohue-Rolfe, A.; Keusch, G.T. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J. Exp. Med. 1986, 163, 1391–1404.
83. Lindberg, A.A.; Brown, J.E.; Stromberg, N.; Westling-Ryd, M.; Schultz, J.E.; Karlsson, K.A. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J. Biol. Chem. 1987, 262, 1779–1785.
84. Keusch, G.T.; Jacewicz, M.; Acheson, D.W.; Donohue-Rolfe, A.; Kane, A.V.; McCluer, R.H. Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e. Infect. Immun. 1995, 63, 1138–1141.
85. Okuda, T.; Tokuda, N.; Numata, S.; Ito, M.; Ohta, M.; Kawamura, K.; Wiels, J.; Urano, T.; Tajima, O.; Furukawa, K.; et al. Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. J. Biol. Chem. 2006, 281, 10230–10235.
86. Brunger, A.T.; Rummel, A. Receptor and substrate interactions of clostridial neurotoxins. Toxicon 2009, 54, 550–560.
87. Nakamura, K.; Kohda, T.; Shibata, Y.; Tsukamoto, K.; Arimitsu, H.; Hayashi, M.; Mukamoto, M.; Sasakawa, N.; Kozaki, S. Unique biological activity of botulinum D/C mosaic neurotoxin in murine species. Infect. Immun. 2012, 80, 2886–2893.
88. Fukuta, S.; Magnani, J.L.; Twiddy, E.M.; Holmes, R.K.; Ginsburg, V. Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-IIb. Infect. Immun. 1988, 56, 1748–1753.
89. Nakayama, H.; Ogawa, H.; Takamori, K.; Iwabuchi, K. GSL-enriched membrane microdomains in innate immune responses. Arch. Immunol. Ther. Exp. 2013, 61, 217–228.
90. Duan, J.; Zhang, J.; Zhao, Y.; Yang, F.; Zhang, X. Ganglioside GM2 modulates the erythrocyte Ca2+-ATPase through its binding to the calmodulin-binding domain and its ‘receptor’. Arch. Biochem. Biophys. 2006, 454, 155–159.
91. Boscher, C.; Zheng, Y.Z.; Lakshminarayan, R.; Johannes, L.; Dennis, J.W.; Foster, L.J.; Nabi, I.R. Galectin-3 protein regulates mobility of N-cadherin and GM1 ganglioside at cell-cell junctions of mammary carcinoma cells. J. Biol. Chem. 2012, 287, 32940–32952.
92. Handa, K.; Hakomori, S.I. Carbohydrate to carbohydrate interaction in development process and cancer progression. Glycoconj. J. 2012, 29, 627–637.
93. Heuss, S.F.; Tarantino, N.; Fantini, J.; Ndiaye-Lobry, D.; Moretti, J.; Israel, A.; Logeat, F. A glycosphingolipid binding domain controls trafficking and activity of the mammalian notch ligand delta-like 1. PLoS ONE 2013, 8, e74392.
94. Singh, P.; Paila, Y.D.; Chattopadhyay, A. Role of glycosphingolipids in the function of human serotonin(1)A receptors. J. Neurochem. 2012, 123, 716–724.
95. Yamashita, T.; Wada, R.; Sasaki, T.; Deng, C.; Bierfreund, U.; Sandhoff, K.; Proia, R.L. A vital role for glycosphingolipid synthesis during development and differentiation. Proc. Natl. Acad. Sci. USA 1999, 96, 9142–9147.
96. Yamashita, T.; Wu, Y.P.; Sandhoff, R.; Werth, N.; Mizukami, H.; Ellis, J.M.; Dupree, J.L.; Geyer, R.; Sandhoff, K.; Proia, R.L. Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proc. Natl. Acad. Sci. USA 2005, 102, 2725–2730.
97. Kumagai, T.; Tanaka, M.; Yokoyama, M.; Sato, T.; Shinkai, T.; Furukawa, K. Early lethality of β-1, 4-galactosyltransferase V-mutant mice by growth retardation. Biochem. Biophys. Res. Commun. 2009, 379, 456–459.
98. Yamashita, T.; Hashiramoto, A.; Haluzik, M.; Mizukami, H.; Beck, S.; Norton, A.; Kono, M.; Tsuji, S.; Daniotti, J.L.; Werth, N.; et al. Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc. Natl. Acad. Sci. USA 2003, 100, 3445–3449.
99. Takamiya, K.; Yamamoto, A.; Furukawa, K.; Yamashiro, S.; Shin, M.; Okada, M.; Fukumoto, S.; Haraguchi, M.; Takeda, N.; Fujimura, K.; et al. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc. Natl. Acad. Sci. USA 1996, 93, 10662–10667.
100. Sheikh, K.A.; Sun, J.; Liu, Y.; Kawai, H.; Crawford, T.O.; Proia, R.L.; Griffin, J.W.; Schnaar, R.L. Mice lacking complex gangliosides developWallerian degeneration and myelination defects. Proc. Natl. Acad. Sci. USA 1999, 96, 7532–7537.
101. Wu, G.; Lu, Z.H.; Kulkarni, N.; Amin, R.; Ledeen, R.W. Mice lacking major brain gangliosides develop parkinsonism. Neurochem. Res. 2011, 36, 1706–1714.
102. Linn, S.C.; Kim, H.S.; Keane, E.M.; Andras, L.M.; Wang, E.; Merrill, A.H. Jr. Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption. Biochem. Soc. Trans. 2001, 29, 831–835.
103. Mullen, T.D.; Hannun, Y.A.; Obeid, L.M. Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochem. J. 2012, 441, 789–802.
104. Holthuis, J.C.; Pomorski, T.; Raggers, R.J.; Sprong, H.; van Meer, G. The organizing potential of sphingolipids in intracellular membrane transport. Physiol. Rev. 2001, 81, 1689–1723.
105. Hanada, K.; Kumagai, K.; Yasuda, S.; Miura, Y.; Kawano, M.; Fukasawa, M.; Nishijima, M. Molecular machinery for non-vesicular trafficking of ceramide. Nature 2003, 426, 803–809.
106. Funakoshi, T.; Yasuda, S.; Fukasawa, M.; Nishijima, M.; Hanada, K. Reconstitution of ATP- and cytosol-dependent transport of de novo synthesized ceramide to the site of sphingomyelin synthesis in semi-intact cells. J. Biol. Chem. 2000, 275, 29938–29945.
107. Maccioni, H.J.; Quiroga, R.; Ferrari, M.L. Cellular and molecular biology of glycosphingolipid glycosylation. J. Neurochem. 2011, 117, 589–602.
108. Buton, X.; Herve, P.; Kubelt, J.; Tannert, A.; Burger, K.N.; Fellmann, P.; Muller, P.; Herrmann, A.; Seigneuret, M.; Devaux, P.F. Transbilayer movement of monohexosylsphingolipids in endoplasmic reticulum and Golgi membranes. Biochemistry 2002, 41, 13106–13115.
109. D’Angelo, G.; Polishchuk, E.; di Tullio, G.; Santoro, M.; fi Campli, A.; Godi, A.; West, G.; Bielawski, J.; Chuang, C.C.; van der Spoel, A.C.; et al. Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide. Nature 2007, 449, 62–67.
110. Halter, D.; Neumann, S.; van Dijk, S.M.; Wolthoorn, J.; de Maziere, A.M.; Vieira, O.V.; Mattjus, P.; Klumperman, J.; van Meer, G.; Sprong, H. Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis. J. Cell Biol. 2007, 179, 101–115.
111. D’Angelo, G.; Uemura, T.; Chuang, C.C.; Polishchuk, E.; Santoro, M.; Ohvo-Rekila, H.; Sato, T.; di Tullio, G.; Varriale, A.; D’Auria, S.; et al. Vesicular and non-vesicular transport feed distinct glycosylation pathways in the Golgi. Nature 2013, 501, 116–120.
112. Kumagai, T.; Sato, T.; Natsuka, S.; Kobayashi, Y.; Zhou, D.; Shinkai, T.; Hayakawa, S.; Furukawa, K. Involvement of murine β-1, 4-galactosyltransferase V in lactosylceramide biosynthesis. Glycoconj. J. 2010, 27, 685–695.
113. Nomura, T.; Takizawa, M.; Aoki, J.; Arai, H.; Inoue, K.; Wakisaka, E.; Yoshizuka, N.; Imokawa, G.; Dohmae, N.; Takio, K.; et al. Purification, cDNA cloning, and expression of UDP-Gal: Glucosylceramide β-1, 4-galactosyltransferase from rat brain. J. Biol. Chem. 1998, 273, 13570–13577.
114. Ishii, A.; Ohta, M.; Watanabe, Y.; Matsuda, K.; Ishiyama, K.; Sakoe, K.; Nakamura, M.; Inokuchi, J.; Sanai, Y.; Saito, M. Expression cloning and functional characterization of human cDNA for ganglioside GM3 synthase. J. Biol. Chem. 1998, 273, 31652–31655.
115. Kojima, Y.; Fukumoto, S.; Furukawa, K.; Okajima, T.; Wiels, J.; Yokoyama, K.; Suzuki, Y.; Urano, T.; Ohta, M.; Furukawa, K. Molecular cloning of globotriaosylceramide/CD77 synthase, a glycosyltransferase that initiates the synthesis of globo series glycosphingolipids. J. Biol. Chem. 2000, 275, 15152–15156.
116. Biellmann, F.; Hulsmeier, A.J.; Zhou, D.; Cinelli, P.; Hennet, T. The Lc3-synthase gene B3gnt5 is essential to pre-implantation development of the murine embryo. BMC Dev. Biol. 2008, 8.
117. Nagata, Y.; Yamashiro, S.; Yodoi, J.; Lloyd, K.O.; Shiku, H.; Furukawa, K. Expression cloning of β 1, 4 N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides. J. Biol. Chem. 1992, 267, 12082–12089.
118. Hidari, J.K.; Ichikawa, S.; Furukawa, K.; Yamasaki, M.; Hirabayashi, Y. β1–4N-acetylgalactosaminyltransferase can synthesize both asialoglycosphingolipid GM2 and glycosphingolipid GM2 in vitro and in vivo: Isolation and characterization of a β1–4N-acetylgalactosaminyltransferase cDNA clone from rat ascites hepatoma cell line AH7974F. Biochem. J. 1994, 303, 957–965.
119. Maccioni, H.J.; Quiroga, R.; Spessott, W. Organization of the synthesis of glycolipid oligosaccharides in the Golgi complex. FEBS Lett. 2011, 585, 1691–1698.
120. Uliana, A.S.; Crespo, P.M.; Martina, J.A.; Daniotti, J.L.; Maccioni, H.J. Modulation of GalT1 and SialT1 sub-Golgi localization by SialT2 expression reveals an organellar level of glycolipid synthesis control. J. Biol. Chem. 2006, 281, 32852–32860.
121. Aureli, M.; Loberto, N.; Chigorno, V.; Prinetti, A.; Sonnino, S. Remodeling of sphingolipids by plasma membrane associated enzymes. Neurochem. Res. 2011, 36, 1636–1644.
122. Kitatani, K.; Idkowiak-Baldys, J.; Hannun, Y.A. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal. 2008, 20, 1010–1018.
123. Ginzburg, L.; Kacher, Y.; Futerman, A.H. The pathogenesis of glycosphingolipid storage disorders. Semin. Cell Dev. Biol. 2004, 15, 417–431.
124. Brunngraber, E.G.; Berra, B.; Zambotti, V. Altered levels of tissue glycoproteins, gangliosides, glycosaminoglycans and lipids in Niemann–Pick’s disease. Clin. Chim. Acta 1973, 48, 173–181.
125. Fahy, E.; Subramaniam, S.; Murphy, R.C.; Nishijima, M.; Raetz, C.R.; Shimizu, T.; Spener, F.; van Meer, G.; Wakelam, M.J.; Dennis, E.A. Update of the LIPID MAPS comprehensive classification system for lipids. J. Lipid Res. 2009, 50, S9–S14.
126. Bremer, E.G.; Schlessinger, J.; Hakomori, S. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 1986, 261, 2434–2440.
127. Hanai, N.; Nores, G.A.; MacLeod, C.; Torres-Mendez, C.R.; Hakomori, S. Ganglioside-mediated modulation of cell growth: Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 1988, 263, 10915–10921.
128. Kawashima, N.; Yoon, S.J.; Itoh, K.; Nakayama, K. Tyrosine kinase activity of epidermal growth factor receptor is regulated by GM3 binding through carbohydrate to carbohydrate interactions. J. Biol. Chem. 2009, 284, 6147–6155.
129. Liu, Y.; Li, R.; Ladisch, S. Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization. J. Biol. Chem. 2004, 279, 36481–36489.
130. Meuillet, E.; Cremel, G.; Dreyfus, H.; Hicks, D. Differential modulation of basic fibroblast and epidermal growth factor receptor activation by ganglioside GM3 in cultured retinal Muller glia. Glia 1996, 17, 206–216.
131. Toledo, M.S.; Suzuki, E.; Handa, K.; Hakomori, S. Cell growth regulation through GM3-enriched microdomain (glycosynapse) in human lung embryonal fibroblast WI38 and its oncogenic transformant VA13. J. Biol. Chem. 2004, 279, 34655–34664.
132. Toledo, M.S.; Suzuki, E.; Handa, K.; Hakomori, S. Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor. J. Biol. Chem. 2005, 280, 16227–16234.
133. Rabin, S.J.; Mocchetti, I. GM1 ganglioside activates the high-affinity nerve growth factor receptor trkA. J. Neurochem. 1995, 65, 347–354.
134. Duchemin, A.M.; Ren, Q.; Mo, L.; Neff, N.H.; Hadjiconstantinou, M. GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain. J. Neurochem. 2002, 81, 696–707.
135. Cazet, A.; Lefebvre, J.; Adriaenssens, E.; Julien, S.; Bobowski, M.; Grigoriadis, A.; Tutt, A.; Tulasne, D.; le Bourhis, X.; Delannoy, P. GD3 synthase expression enhances proliferation and tumor growth of MDA-MB-231 breast cancer cells through c-Met activation. Mol. Cancer Res. 2010, 8, 1526–1535.
136. Cazet, A.; Groux-Degroote, S.; Teylaert, B.; Kwon, K.M.; Lehoux, S.; Slomianny, C.; Kim, C.H.; le Bourhis, X.; Delannoy, P. GD3 synthase overexpression enhances proliferation and migration of MDA-MB-231 breast cancer cells. Biol. Chem. 2009, 390, 601–609.
137. Cazet, A.; Bobowski, M.; Rombouts, Y.; Lefebvre, J.; Steenackers, A.; Popa, I.; Guerardel, Y.; le Bourhis, X.; Tulasne, D.; Delannoy, P. The ganglioside GD2 induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the GD3 synthase. Glycobiology 2012, 22, 806–816.
138. Yates, A.J.; Saqr, H.E.; van Brocklyn, J. Ganglioside modulation of the PDGF receptor. A model for ganglioside functions. J. Neurooncol. 1995, 24, 65–73.
139. Hynds, D.L.; Summers, M.; van Brocklyn, J.; O’Dorisio, M.S.; Yates, A.J. Gangliosides inhibit platelet-derived growth factor-stimulated growth, receptor phosphorylation, and dimerization in neuroblastoma SH-SY5Y cells. J. Neurochem. 1995, 65, 2251–2258.
140. Lang, Z.; Guerrera, M.; Li, R.; Ladisch, S. Ganglioside GD1a enhances VEGF-induced endothelial cell proliferation and migration. Biochem. Biophys. Res. Commun. 2001, 282, 1031–1037.
141. Chung, T.W.; Kim, S.J.; Choi, H.J.; Kim, K.J.; Kim, M.J.; Kim, S.H.; Lee, H.J.; Ko, J.H.; Lee, Y.C.; Suzuki, A.; et al. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: Direct interaction of GM3 with VEGFR-2. Glycobiology 2009, 19, 229–239.
142. Kabayama, K.; Sato, T.; Kitamura, F.; Uemura, S.; Kang, B.W.; Igarashi, Y.; Inokuchi, J. TNF -induced insulin resistance in adipocytes as a membrane microdomain disorder: Involvement of ganglioside GM3. Glycobiology 2005, 15, 21–29.
143. Sasaki, A.; Hata, K.; Suzuki, S.; Sawada, M.; Wada, T.; Yamaguchi, K.; Obinata, M.; Tateno, H.; Suzuki, H.; Miyagi, T. Overexpression of plasma membrane-associated sialidase attenuates insulin signaling in transgenic mice. J. Biol. Chem. 2003, 278, 27896–27902.
144. Kaucic, K.; Liu, Y.; Ladisch, S. Modulation of growth factor signaling by gangliosides: Positive or negative? Methods Enzymol. 2006, 417, 168–185.
145. Farooqui, T.; Franklin, T.; Pearl, D.K.; Yates, A.J. Ganglioside GM1 enhances induction by nerve growth factor of a putative dimer of TrkA. J. Neurochem. 1997, 68, 2348–2355.
146. Mutoh, T.; Hamano, T.; Tokuda, A.; Kuriyama, M. Unglycosylated Trk protein does not co-localize nor associate with ganglioside GM1 in stable clone of PC12 cells overexpressing Trk (PCtrk cells). Glycoconj. J. 2000, 17, 233–237.
147. Ichikawa, N.; Iwabuchi, K.; Kurihara, H.; Ishii, K.; Kobayashi, T.; Sasaki, T.; Hattori, N.; Mizuno, Y.; Hozumi, K.; Yamada, Y.; et al. Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth. J. Cell Sci. 2009, 122, 289–299.
148. Maglione, V.; Marchi, P.; Di Pardo, A.; Lingrell, S.; Horkey, M.; Tidmarsh, E.; Sipione, S. Impaired ganglioside metabolism in Huntington’s disease and neuroprotective role of GM1. J. Neurosci. 2010, 30, 4072–4080.
149. Di Pardo, A.; Maglione, V.; Alpaugh, M.; Horkey, M.; Atwal, R.S.; Sassone, J.; Ciammola, A.; Steffan, J.S.; Fouad, K.; Truant, R.; et al. Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice. Proc. Natl. Acad. Sci. USA 2012, 109, 3528–3533.
150. Nojiri, H.; Stroud, M.; Hakomori, S. A specific type of ganglioside as a modulator of insulin-dependent cell growth and insulin receptor tyrosine kinase activity: Possible association of ganglioside-induced inhibition of insulin receptor function and monocytic differentiation induction in HL-60 cells. J. Biol. Chem. 1991, 266, 4531–4537.
151. Sato, T.; Nihei, Y.; Nagafuku, M.; Tagami, S.; Chin, R.; Kawamura, M.; Miyazaki, S.; Suzuki, M.; Sugahara, S.; Takahashi, Y.; et al. Circulating levels of ganglioside GM3 in metabolic syndrome: A pilot study. Obes. Res. Clin. Pract. 2008, 2.
152. Veillon, L.; Go, S.; Matsuyama, W.; Suzuki, A.; Nagasaki, M.; Yatomi, Y.; Inokuchi, J. Identification of ganglioside GM3 molecular species in human serum associated with risk factors of metabolic syndrome. PLoS ONE 2015, 10, e0129645.
153. Merrill, A.H.; Jr.; Stokes, T.H.; Momin, A.; Park, H.; Portz, B.J.; Kelly, S.; Wang, E.; Sullards, M.C.; Wang, M.D. Sphingolipidomics: A valuable tool for understanding the roles of sphingolipids in biology and disease. J. Lipid Res. 2009, 50, S97–S102.
154. Hannun, Y.A.; Obeid, L.M. Many ceramides. J. Biol. Chem. 2011, 286, 27855–27862.
155. Simons, K.; Ikonen, E. Functional rafts in cell membranes. Nature 1997, 387, 569–572.
156. Hakomori, S.; Handa, K.; Iwabuchi, K.; Yamamura, S.; Prinetti, A. New insights in glycosphingolipid function: “glycosignaling domain”, a cell surface assembly of glycosphingolipids with signal transducer molecules, involved in cell adhesion coupled with signaling. Glycobiology 1998, 8, xi–xix.
157. Regina Todeschini, A.; Hakomori, S.I. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim. Biophys. Acta 2008, 1780, 421–433.
158. Mahfoud, R.; Garmy, N.; Maresca, M.; Yahi, N.; Puigserver, A.; Fantini, J. Identification of a common sphingolipid-binding domain in Alzheimer, prion, and HIV-1 proteins. J. Biol. Chem. 2002, 277, 11292–11296.
159. Lingwood, C.A.; Branch, D.R. The role of glycosphingolipids in HIV/AIDS. Discov. Med. 2011, 11, 303–313.
160. Nehete, P.N.; Vela, E.M.; Hossain, M.M.; Sarkar, A.K.; Yahi, N.; Fantini, J.; Sastry, K.J. A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains. Antivir. Res. 2002, 56, 233–251.
161. Delezay, O.; Hammache, D.; Fantini, J.; Yahi, N. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids. Biochemistry 1996, 35, 15663–15671.
162. Fantini, J.; Yahi, N. Molecular basis for the glycosphingolipid-binding specificity of -synuclein: Key role of tyrosine 39 in membrane insertion. J. Mol. Biol. 2011, 408, 654–669.
163. Chattopadhyay, A.; Paila, Y.D.; Shrivastava, S.; Tiwari, S.; Singh, P.; Fantini, J. Sphingolipid-binding domain in the serotonin1A receptor. Adv. Exp. Med. Biol. 2012, 749, 279–293.
164. Maresca, M.; Derghal, A.; Caravagna, C.; Dudin, S.; Fantini, J. Controlled aggregation of adenine by sugars: Physicochemical studies, molecular modelling simulations of sugar-aromatic CH-pi stacking interactions, and biological significance. Phys. Chem. Chem. Phys. 2008, 10, 2792–2800.
165. Soltyk, A.M.; MacKenzie, C.R.; Wolski, V.M.; Hirama, T.; Kitov, P.I.; Bundle, D.R.; Brunton, J.L. A mutational analysis of the globotriaosylceramide-binding sites of verotoxin VT1. J. Biol. Chem. 2002, 277, 5351–5359.
166. Ling, H.; Boodhoo, A.; Hazes, B.; Cummings, M.D.; Armstrong, G.D.; Brunton, J.L.; Read, R.J. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry 1998, 37, 1777–1788.
167. Maloney, M.D.; Lingwood, C.A. CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: Implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis. J. Exp. Med. 1994, 180, 191–201.
168. D’Angelo, G.; Capasso, S.; Sticco, L.; Russo, D. Glycosphingolipids: Synthesis and functions. FEBS J. 2013, 280, 6338–6353.
169. Ichikawa, S.; Nakajo, N.; Sakiyama, H.; Hirabayashi, Y. A mouse B16 melanoma mutant deficient in glycolipids. Proc. Natl. Acad. Sci. USA 1994, 91, 2703–2707.
170. Liang, Y.J.; Kuo, H.H.; Lin, C.H.; Chen, Y.Y.; Yang, B.C.; Cheng, Y.Y.; Yu, A.L.; Khoo, K.H.; Yu, J. Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation. Proc. Natl. Acad. Sci. USA 2010, 107, 22564–22569.
171. Park, H.; Haynes, C.A.; Nairn, A.V.; Kulik, M.; Dalton, S.; Moremen, K.; Merrill, A.H.; Jr. Transcript profiling and lipidomic analysis of ceramide subspecies in mouse embryonic stem cells and embryoid bodies. J. Lipid Res. 2010, 51, 480–489.
172. Liang, Y.J.; Yang, B.C.; Chen, J.M.; Lin, Y.H.; Huang, C.L.; Cheng, Y.Y.; Hsu, C.Y.; Khoo, K.H.; Shen, C.N.; Yu, J. Changes in glycosphingolipid composition during differentiation of human embryonic stem cells to ectodermal or endodermal lineages. Stem Cells 2011, 29, 1995–2004.
173. Yu, R.K.; Tsai, Y.T.; Ariga, T. Functional roles of gangliosides in neurodevelopment: An overview of recent advances. Neurochem. Res. 2012, 37, 1230–1244.
174. Suzuki, Y.; Yanagisawa, M.; Yagi, H.; Nakatani, Y.; Yu, R.K. Involvement of β1-integrin up-regulation in basic fibroblast growth factor- and epidermal growth factor-induced proliferation of mouse neuroepithelial cells. J. Biol. Chem. 2010, 285, 18443–18451.
175. Tsai, Y.T.; Yu, R.K. Epigenetic activation of mouse ganglioside synthase genes: Implications for neurogenesis. J. Neurochem. 2014, 128, 101–110.
176. Gurdon, J.B.; Bourillot, P.Y. Morphogen gradient interpretation. Nature 2001, 413, 797–803.
177. Wegner, M.S.; Schiffmann, S.; Parnham, M.J.; Geisslinger, G.; Grosch, S. The enigma of ceramide synthase regulation in mammalian cells. Prog. Lipid Res. 2016, 63, 93–119.
178. Borbat, P.P.; Costa-Filho, A.J.; Earle, K.A.; Moscicki, J.K.; Freed, J.H. Electron spin resonance in studies of membranes and proteins. Science 2001, 291, 266–269.
179. Marsh, D.; Horvath, L.I. Structure, dynamics and composition of the lipid-protein interface: Perspectives from spin-labelling. Biochim. Biophys. Acta 1998, 1376, 267–296.
180. Ionova, I.V.; Livshits, V.A.; Marsh, D. Phase diagram of ternary cholesterol/palmitoylsphingomyelin/palmitoyloleoyl-phosphatidylcholine mixtures: Spin-label EPR study of lipid-raft formation. Biophys. J. 2012, 102, 1856–1865.
181. Feng, J.; Lindahl, P.A. Effect of sodium sulfide on Ni-containing carbon monoxide dehydrogenases. J. Am. Chem. Soc. 2004, 126, 9094–9100.
182. Esmann, M.; Marsh, D.; Schwarzmann, G.; Sandhoff, K. Ganglioside-protein interactions: Spin-label electron spin resonance studies with (Na+, K+)-ATPase membranes. Biochemistry 1988, 27, 2398–2403.
183. Haberkant, P.; Schmitt, O.; Contreras, F.X.; Thiele, C.; Hanada, K.; Sprong, H.; Reinhard, C.; Wieland, F.T.; Brugger, B. Protein-sphingolipid interactions within cellular membranes. J. Lipid Res. 2008, 49, 251–262.
184. Haberkant, P.; Stein, F.; Hoglinger, D.; Gerl, M.J.; Brugger, B.; van Veldhoven, P.P.; Krijgsveld, J.; Gavin, A.C.; Schultz, C. Bifunctional sphingosine for cell-based analysis of protein-sphingolipid interactions. ACS Chem. Biol. 2016, 11, 222–230.